Palliare
PrivateLast Round
Series A
Jun 28, 2021
Total Funding Raised
$10.84M
Company Overview
Palliare is a medical device company that develops and manufactures advanced insufflation and surgical smoke evacuation technologies for laparoscopic, endoluminal, endoscopic, and robotic surgical procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Palliare Comparables
Compare Palliare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lexion Medical | 86% | |
| I.C. Medical, Inc. | 81% | |
| CONMED Corporation | 81% | |
Palliare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 28, 2021 | ||||
| Grant | Nov 1, 2020 |
Palliare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Western Development Commission | Series A |
| Seroba Life Sciences | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors grew 84% MoM, from 816 to 1.5K.
- Jun 28, 2021
Raised $8M led by Seroba Life Sciences
Palliare Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Palliare's valuation, stock price, and market status.